Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial
Authors
Daugla, D MGami, J P
Gamougam, K
Naibei, N
Mbainadji, L
Narbé, M
Toralta, J
Kodbesse, B
Ngadoua, C
Coldiron, M E
Fermon, F
Page, A-L
Djingarey, M H
Hugonnet, S
Harrison, O B
Rebbetts, L S
Tekletsion, Y
Watkins, E R
Hill, D
Caugant, D A
Chandramohan, D
Hassan-King, M
Manigart, O
Nascimento, M
Woukeu, A
Trotter, C
Stuart, J M
Maiden, M C J
Greenwood, B M
Affiliation
Centre de Support en Santé International (CSSI), N'Djamena, Chad.Issue Date
2013-09-11
Metadata
Show full item recordJournal
LancetAbstract
A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African meningitis belt. We studied the effect of PsA-TT on meningococcal meningitis and carriage in Chad during a serogroup A meningococcal meningitis epidemic.Publisher
ElsevierPubMed ID
24035220Language
enISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(13)61612-8
Scopus Count
Collections
Related articles
- Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
- Authors: Novak RT, Kambou JL, Diomandé FV, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrébéogo SR, Clark TA
- Issue date: 2012 Oct
- Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
- Authors: Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa., Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G
- Issue date: 2013 Mar 1
- Meningococcal carriage in the African meningitis belt.
- Authors: MenAfriCar Consortium.
- Issue date: 2013 Aug
- Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
- Authors: Kristiansen PA, Ba AK, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga IM, Misegades L, Clark TA, Préziosi MP, Caugant DA
- Issue date: 2014 Dec 4
- Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
- Authors: Meyer SA, Kambou JL, Cohn A, Goodson JL, Flannery B, Medah I, Messonnier N, Novak R, Diomande F, Djingarey MH, Clark TA, Yameogo I, Fall A, Wannemuehler K
- Issue date: 2015 Mar 17